Dr. Levitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
ONCare Specialty Consultants
Atlanta, GA 30327
Summary
- Chad Levitt, MD is an Atlanta-based oncology specialist with significant experience in hospice and palliative medicine, colorectal, pancreatic, breast, and lung cancer. A graduate of Emory University School of Medicine, he completed his residency in Radiation Oncology at the same institution. He has held several leadership roles in the medical field, including President/Managing Partner at ONCare Specialty Consultants, and is currently renowned for founding Radiotherapy Associates of Forsyth. Dr. Levitt has contributed important research on prostate cancer and airway disorders to prominent publications and has consistently received "Top Doctor" accolades from Atlanta Magazine from 2014-2022.
Education & Training
Emory University School of MedicineResidency, Radiation Oncology, 2000 - 2004- Emory University School of MedicineClass of 1999
Certifications & Licensure
AZ State Medical License 2023 - 2027
TX State Medical License 2023 - 2026
TN State Medical License 2024 - 2026
MD State Medical License 2023 - 2026
MT State Medical License 2024 - 2026
WI State Medical License 2024 - 2025
AL State Medical License 2024 - 2025- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctor Castle Connolly, 2015-2022
- Atlanta Magazine: Top Doctors Castle Connolly, 2014
Publications & Presentations
PubMed
- 20 citationsAirway disorders in hemifacial microsomia.Steven R. Cohen, Chad A. Levitt, Catherine Simms, Fernando D. Burstein
Plastic and Reconstructive Surgery. 1999-01-01
Journal Articles
- Seed Marker-Based IGRT for Prostate Cancer: Excellent Preliminary Toxicity OutcomesScarbrough, Ting, Golden, Levitt, International Journal of Radiation Oncology, Biology, and Physics, 7/2007
Abstracts/Posters
- 10-year Biochemical (PSA) Control of Early Stage Gleason Score 4+4=8 Prostate Cancer Treated with I-125 Brachytherapy + Local External Beam Radiation Therapy Is Improv...Schnell, Benton, Critz, Gargus, Gregory, Levitt, Merlin, Rosenbaum, Shrake, Stillwagon, International Journal of Radiation Oncology, biology, and Physics, 10/2010
Industry Relationships
- Medical Director, Providence RadiotherapyMedical director for development of proton therapy centers and networks2010 - 2020
- Surveyor, American College of RadiologyAssist with credentialling and certification of radiation oncology departments around the country2011 - 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
